We use cells from the patient, for the patient.
Autologous cell therapy uses an individual’s cells harvested from a small amount of their skin. The skin is processed and the cells are multiplied and turned into a custom graft.
TeVido’s therapy-as-a-service (TAAS) model will bring regenerative therapy to clinics around the world. Our process evolved from our work in biofabrication and 3D bioprinting where we have focused efforts to enable physicians to treat skin pigmentation disorders, such as vitiligo and nipple areola reconstruction for breast cancer survivors.
We are still in the Research and Development phase.
Return to Home